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Introduction: Thyroid nodules are a common condition. Overall, 20% of the nodules assessed with FNAB
correspond to the follicular pattern. A partial thyroidectomy is the minimal procedure that should be
performed to determine the nature of these nodules. Some authors have suggested performing a total
thyroidectomy based on the elimination of reoperation and ultrasound follow-up. The aim of this study
was to evaluate the most cost-useful surgical strategy in a patient with an undetermined nodule,
assessing complications, reoperation, recurrence and costs.
Material and methods: A cost-utility study was designed to compare hemithyroidectomy and total thy-
roidectomy. The outcomes were complications (deﬁnitive RLN palsy, permanent hypoparathyroidism,
reoperation for cancer, and recurrence of the disease), direct costs and utility. We used the payer
perspective at 5 years. A deterministic and probabilistic sensitivity analysis was completed.
Results: In a deterministic analysis, the cost, utility and cost-utility ratio was COP $12.981.801, 44.5 and
COP $291.310 for total thyroidectomy and COP $14.309.889, 42.0 and $340.044 for partial thyroidectomy,
respectively. The incremental cost-utility ratio was $535.302 favoring total thyroidectomy. Partial
thyroidectomy was more cost-effective when the risks of RLN injury and deﬁnitive hypoparathyroidism
were greater than 8% and 9% in total thyroidectomy, respectively. In total, 46.8% of the simulations for
partial thyroidectomy were located in the quadrant of more costly and less effective.
Conclusion: Under a common range of complications, and considering the patient's preference and costs,
total thyroidectomy should be selected as the most cost-effective treatment for patients with thyroid
nodules and follicular patterns.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Thyroid nodules are a very common condition. It is estimated
that 3e7% of world population have palpable thyroid nodules, and
this prevalence may reach 76% when ultrasonography is used as a
screening tool [1]. When a thyroid nodule is detected, the most
important step in the assessment is to determine whether this
nodule is a carcinoma or an adenoma, which is determined via ﬁne
needle aspiration biopsy (FNAB). It is accepted that 5e7% of all
nodules are malignant [2]. However, in 15e20% of nodules assessedool of Medicine, Universidad
opista norte, Chia, Colombia.
.co, asanabriq@hotmail.com
by Elsevier Ltd. All rights reservedwith FNAB, it is not possible to determine the true condition of the
malignancy or benignity; these are assessed by follicular patterns
or undetermined nodules. Recently, these nodules were included
into category 4 in the Bethesda system [3]. The nodules may be
malignant in 20e30% of cases [4,5]. Currently, it is accepted that in
these cases, a partial thyroidectomy is the minimum surgical pro-
cedure that should be performed to determine the nature of the
nodule. This strategy has some advantages, such as the mainte-
nance of thyroid function without hormone supplementation, the
lower risk of recurrent laryngeal nerve (RLN) injury and the null
risk of hypoparathyroidism. However, it also has some disadvan-
tages, such as the need to reoperate on the patient if the pathology
report conﬁrms a malignancy, the obligation to perform an ultra-
sonographic follow-up of the remnant lobe and the later risk of
reoperation if another suspicious nodule appears in this lobe,
which could reach 50% at 10 years [6]. Consequently, some authors.
C. Corso et al. / International Journal of Surgery 12 (2014) 837e842838have suggested the performance of a total thyroidectomy based on
the elimination of the possibility of reoperation and ultrasound
follow-up; however, this option runs the risk of an increased rate of
RLN injury and deﬁnitive hypoparathyroidism and of the need for
hormone supplementation for the rest of the patient's life. There is
no agreement as towhich of these alternatives should be chosen. In
the scenario of a patient with goiter, which is common in some
iodine-deﬁcient areas, such as Latin America, Europe and Asia, the
conditions of the patient modify the baseline in favor of one or the
other procedure. In this speciﬁc case, the advantage of preserving
the thyroid function is lost, and therefore, leaving a remnant lobe
will still carry the risk of reoperation, only securing the advantage
of less RLN injury. To date, there is no information directly
comparing the two surgical procedures and assessing their clinical
and cost outcomes concomitantly.
The aim of this study was to evaluate the most cost-effective
surgical strategy in a patient with an undetermined nodule in the
FNAB, considering the complications, reoperation, recurrence and
hormonal support in the long term.
2. Material and methods
This is a cost-utility study. The protocol was approved by the
ethics committee and supported by Universidad de La Sabana. The
cases on which the study is based involve adult patients with a
thyroid nodule and a reported follicular pattern in the FNAB in a
general hospital in a developing country as Colombia. Based on thisFig. 1. Decisiscenario, we excluded patients with comorbidities, previous neck
or thyroid surgery, previous radioiodine therapy and pregnancy.
2.1. Alternatives
A decision tree with a Markov chain was assembled with the
Treeage Pro (Treeage software, Inc; Williamstown, MA, USA) to
compare two strategies, hemithyroidectomy and total thyroidec-
tomy, as the initial surgical procedure (Fig. 1). The Markov nodes
were introduced for the risk of recurrence on the contralateral lobe
after partial thyroidectomy. The outcomes included were compli-
cations (deﬁnitive RLN palsy, permanent hypoparathyroidism,
reoperation for cancer, and recurrence of the disease in the
contralateral lobe), direct costs and utility. The time period selected
was 5 years.
2.2. Complications and follow up
We completed a systematic review of the literature in the
PubMed database with the terms “hypothyroidism”, “thyroid
nodule”, “therapeutics”, “treatment” and “thyroidectomy,” search-
ing for data on the incidence of complications for each alternative.
We assumed that total thyroidectomy could produce deﬁnitive RLN
and permanent hypoparathyroidism, but the possibility of reoper-
ation and the necessity of follow-up were null. On the contrary,
hemithyroidectomy could have RLN palsy, but not permanent hy-
poparathyroidism; a risk of early reoperation was present if aon tree.
Table 1
Incidence of complications by surgical procedure.
Complications Total thyroidectomy
(%, range for
sensitivity analysis)
Partial thyroidectomy
(%, range for
sensitivity analysis)
RLN deﬁnitive palsy in
primary surgical procedure
1 (0e50) 0.5 (0e50)
Permanent hypoparathyroidism
in primary surgical procedure
2 (1e50) 0
RLN deﬁnitive palsy in
reoperation
0 5.0 (0e50)
Permanent hypoparathyroidism
in reoperation
0 9.0 (0e50)
Reoperation for postoperative
malignancy ﬁnding
0 20 (0e50)
Reoperation for recurrence
of nodule on the
contralateral lobe
0 10 (1e99)
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of late reoperationwas present if a recurrence of the nodules in the
remnant lobe was noted upon obligatory follow up. We also
assumed that the rate of complications was higher in cases of
reoperation. The follow up consisted of ultrasound and thyroid
function tests every 6 months. The treatment complications were
considered to include the following: for RLN injury, we considered
vocal therapy up to 6 months; and for hypoparathyroidism, we
considered the daily provision of 3600mg of calcium and 0.5mcg of
vitamin D, with a trimestral measurement of serum calcium levels.
2.3. Costs
We used the payer perspective and considered only direct costs.
We selected a cohort of 50 patients treated with each alternative by
one of the authors and recorded the source used from clinical and
administrative charts using a micro-costing method. Speciﬁc costs
included honoraria and resources for the primary surgical proce-
dure, operative time, inpatient length-of-stay, and resources of
reoperation, follow-up tests (biochemical and imaging), treatment
of complications and hormone supplementation. The total cost was
calculated using the number of resources used and multiplying this
value according to a national prizes manual (SOAT 2012), in com-
parisonwith the costs obtained from public contracts, as previously
reported in other study [7]. For the cost calculation of the surgical
procedure, we used aMonte Carlo probabilistic simulationwith 500
iterations, with the primary data adjusted by operative time, to
include the variability among hospitals and surgeons. For the follow
up, we used amicro-costingmethod from the clinical charts, and an
adjustment for the months of follow-up was made in order to
calculate total costs. We used the mean, lowest and highest values
obtained from this calculation for the sensitivityanalysis. As the time
period assessed was longer than a year, an annual 3% discount for
costs andutilitywas applied.1dollar¼2800COP (Colombianpesos).
2.4. Utility
For utility, we selected a preference measurement in a 1e10 vi-
sual analog scale using the following values: 1 for surgical pro-
cedures with any deﬁnitive complication, 10 for those without
complication and 5 for cases which required a reoperation but had
no complications. These preferences scales represent the weight a
decision maker put in the outcome and have been widely used in
other studies that assess utilities [8,9]. The numbers were obtained
surveying surgeons involved in themanagement of thyroid diseases.
2.5. Data analysis
Categorical variables were presented as percentages and ranges,
and continuous variables, as means and standard deviations. A
deterministic one-way, two-way and tornado sensitivity analysis
was performed for complications, reoperation, recurrence, costs
and utility of the intermediate outcome of reoperation without
complication. The incremental cost-utility ratio was calculated at
the end of the 5 years tomake comparisons. We also made a simple
Monte Carlo probabilistic analysis using distributions for the vari-
ables previously reported (Table 3). The incremental cost-utility
distribution was represented in the fourth quadrant graphic.
3. Results
The values obtained from the systematic review for complica-
tions, reoperation and recurrence of the disease are shown in
Table 1 [10e15]. The risk of RLN deﬁnitive palsy was 1% for total
thyroidectomy and 0.5% for partial thyroidectomy; of permanenthypoparathyroidism in total thyroidectomy, 2%; of RLN deﬁnitive
palsy in any reoperation, 5%; of permanent hypoparathyroidism in
any reoperation, 9%; of reoperation for malignancy in partial thy-
roidectomy, 20%; and of recurrence at 5 years, 10%. The net present
value for utility at ﬁve years was 45.8 for surgery without compli-
cations, 22.9 for reoperation without any complications and 4.58
for surgery with any complications. For all of these cases, we used
the same range for sensitivity analysis (4.58e45.8). The net present
values for the costs calculated for each ﬁnal outcome are shown in
Table 2. The higher cost was incurred for a patient with a partial
thyroidectomy who required a reoperation for any cause and who
had deﬁnitive hypoparathyroidism as a complication. The lowest
cost was incurred for a patient with a partial thyroidectomy
without any complications.
After rolling back in a deterministic analysis, the cost, utility and
cost-utility ratios were COP $12.981.801, 44.5 and COP $291.310 for
total thyroidectomy and COP $14.309.889, 42.0 and $340.044 for
partial thyroidectomy, respectively. The incremental cost-utility
ratio was 535.302, favoring total thyroidectomy.
3.1. Deterministic sensitivity analysis
For RLN deﬁnitive palsy and permanent hypoparathyroidism,
the single way sensitivity analysis showed that partial thyroidec-
tomy was more cost-effective than total thyroidectomy when the
risks were superior to 8% and 9%, respectively. In cases of reoper-
ation for malignancy, partial thyroidectomy was superior when the
risk was lower than 11% and for reoperation for recurrence when
the risk was lower than 7%, respectively. The tornado diagram
showed that the most relevant variables were the risk of perma-
nent hypoparathyroidism and the risk of recurrence at 5 years, both
of them dominated in most clinical scenarios by total thyroidec-
tomy, as shown.
3.2. Probabilistic sensitivity analysis
The probabilistic cost-utility calculations are shown in Table 4.
As shown, the cost was higher and the utility was lower for partial
thyroidectomy, with the result of complete dominance by total
thyroidectomy. Fig. 2 shows the four quadrant plane for cost-utility.
Overall, 46.8% of the simulations for partial thyroidectomy were
located in quadrant II (more costly and less effective).
4. Discussion
Thyroid nodules are very common in the general population.
The Framingham study determined that at least 4e8% of adults
Table 2
Direct costs value. (Colombian pesos).
Total NPV at 5 years Lower value Higher value
Total thyroidectomy without complications $ 2.823.511 $ (12.930.856) $ (9.308.176) $ (30.822.842)
Partial thyroidectomy without complications $ 1.671.847 $ (7.656.568) $ (5.408.596) $ (11.180.809)
Total thyroidectomy with RLN palsy $ 2.839.363 $ (13.003.453) $ (7.823.307) $ (26.567.286)
Total thyroidectomy with hypoparathyroidism $ 3.371.791 $ (15.441.818) $ (12.415.855) $ (26.567.286)
Partial thyroidectomy with RLN palsy $ 2.157.331 $ (9.879.943) $ (4.739.061) $ (16.168.385)
Partial thyroidectomy with hypoparathyroidism $ 2.689.759 $ (12.318.307) $ (9.331.610) $ (16.168.385)
Partial thyroidectomy with reoperation and without complications $ 3.813.325 $ (17.463.913) $ (11.632.526) $ (31.604.750)
Partial thyroidectomy with reoperation and with RLN palsy $ 3.829.177 $ (17.536.511) $ (10.147.657) $ (27.349.195)
Partial thyroidectomy with reoperation and with hypoparathyroidism $ 4.361.605 $ (19.974.875) $ (14.740.206) $ (27.349.195)
Partial thyroidectomy with late reoperation and without complications $ 3.343.693 $ (15.313.136) $ (10.817.192) $ (22.361.619)
C. Corso et al. / International Journal of Surgery 12 (2014) 837e842840have a clinically palpable nodules [2], and this number can reach
almost 76% if ultrasonography is used [1]. These numbers can ever
be higher if the population lives in iodine-deﬁcient areas, such as
Latin America, Asia and Europe [12]. The most relevant challenge
for surgeons facing a patient with a thyroid nodule is to deﬁne
whether it is malignant or benign. This classiﬁcation is routinely
performed with a FNAB, which has a high sensitivity and speciﬁcity
[16]. However, in at least 15e20% of cases [17], the cytological re-
sults do not offer enough information to determine the type of
nodule, resulting in what is currently called an undetermined,
follicular pattern or a follicular neoplasm, under the recent
Bethesda classiﬁcation [18]. In these cases, the ﬁnal diagnosis can
only be made through a histopathological study of the surgical
specimen. The most accepted approach in these cases is the per-
formance of a partial thyroidectomy of the suspicious side, with or
without frozen biopsy, to deﬁne the true pathological result and
extent of the surgery (total or partial thyroidectomy). If the deﬁn-
itive result conﬁrms a malignant nodule, a total thyroidectomy is
indicated, but if the results discard this conclusion, the surgical
procedure can ﬁnish with a partial resection. The avoidance of a
total thyroidectomy in a benign condition offers the advantage of
preserving at least 50% of the gland volume. This option allows the
consequent preservation of its function without hormoneTable 3
Values used in distributions for the probabilistic analysis.
Index Variable name Description
1 RLN_injury_TT RLN injury total thyroidectomy
2 RLN_injury_PT RLN injury partial thyroidectomy
3 RLN_injury_reoperation RLN injury reoperation
4 Hypocal_TT Hypocalcemia after total thyroidectomy
5 Hypocal_reoperation Hypocalcemia after reoperation
6 reoperation Reoperation rate
7 utility_reoperation Utility for reoperation
8 Recurrent Recurrence rate
9 costttnocompl Costs in total thyroidectomy without complication
10 costhtnocomp Costs in partial thyroidectomy without complication
11 costttlrninjury Costs in total thyroidectomy with RLN injury
12 costtthypopara Costs in total thyroidectomy with hypoparathyroidi
13 costhtrecurnocomp Costs in partial thyroidectomy after recurrence and
14 costhtlrninjury Costs in partial thyroidectomy with RLN injury
15 cosththypop Costs in partial thyroidectomy and hypoparathyroid
16 costhtreopnocomp Cost in partial thyroidectomy and reoperation with
17 costhtreoplrninjury Costs in partial thyroidectomy and reoperation with
18 costhtreophypoparat Costs in partial thyroidectomy after reoperation and
Table 4
Probabilistic incremental cost-utility values.
Strategy Cost Incremental cost Utility
Total thyroidectomy $13.447.811 44.01
Partial thyroidectomy $14.713.565 $1.265.754 42.39supplementation and a decrease in the risk of deﬁnitive hypo-
parathyroidism and bilateral RLN palsy rates to zero, but it also
carries the risk of an early reoperation due to a malignancy rate of
approximately 30%. Long term follow-up of the remnant lobe is
necessary, and the latent risk of a late reoperation due to nodule
recurrence in the remaining lobe could reach 50% at 180 months
[13]. Many authors have recommended choosing a total thyroid-
ectomy, based on the advantages of reducing the rates of reopera-
tion for malignancy or recurrence and reducing the need for follow-
up to zero, but this choice incurs the price of a higher risk of
bilateral RLN palsy and permanent hypoparathyroidism. However,
factors outside of the potential complications should also be
considered whenmaking a decision. These strategies have different
costs. In total thyroidectomy, the costs associated with complica-
tion management could be high, but in partial thyroidectomy, the
cost of a reintervention and follow-up could also be important.
Additionally, both strategies have different impacts on the quality
of life. While a complication can be devastating, reoperation and
permanent uncertainty about the condition of the remaining lobe
can also cause signiﬁcant anxiety. Up to now, we have been unable
to identify a randomized controlled trial comparing these alterna-
tives and considering all outcomes, and so our decision is based on
our own personal criteria and experience.Type Parameter 1 Parameter 2 Parameter 3
Triangular 0 0.01 0.05
Triangular 0 0.005 0.01
Triangular 0 0.005 0.01
Triangular 0 0.02 0.05
Triangular 0 0.05 0.1
Beta 20 80
Normal 5 3
Beta 10 90
Log-normal 16.38 0.245
s Log-normal 15.85 0.245
Log-normal 16.38 0.245
sm Log-normal 16.55 0.245
without complications Log-normal 16.54 0.245
Log-normal 16.11 0.245
ism Log-normal 16.33 0.245
out complications Log-normal 16.68 0.245
RLN injury Log-normal 16.68 0.245
hypoparathyroidism Log-normal 16.81 0.245
Incremental utility C/E ratio Incremental C/E ratio (ICER)
$305.536
1.61 $347.068 $786.182
Fig. 2. Probabilistic quadrant plane for cost-utility.
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manage more than three variables simultaneously when making a
decision [19]. Therefore, in this particular problem, the number of
variables to take into account when choosing the best surgical
alternative is sufﬁciently high to make the decision very difﬁcult.
An approach to these cases is the use of decision analysis. This
methodology allows the introduction of a higher number of vari-
ables, facilitating a sensitivity analysis for the different clinical
scenarios. As among the important variables are cost and prefer-
ence, this method also allows their inclusion into the model.
This study showed that, with the accepted frequency of com-
plications reported at high volume centers, approximately 2%, the
cost-utility of the total thyroidectomy is the best option. Even in
scenarios where the frequency could be even higher, total thy-
roidectomy maintains its dominance. Only in improbable cases of
rates of permanent hypoparathyroidism of RLN palsy higher than
9% would partial thyroidectomy be a good option. In conditions,
such as Graves' disease and goiter, some authors [20e22] have
shown in randomized controlled trials that more extensive pro-
cedures (total or near total thyroidectomy) have the same rate of
complications but a lower rate of late recurrence. However, these
trials did not introduce the cost factor into their design.
The conclusion is also similar when the reported rates of reop-
eration for an unexpected malignancy found after hemi-
thyroidectomy were included in the model. Classically, a risk of
malignancy of 20% has been accepted. The recent introduction of
the Bethesda classiﬁcation [3], with its more speciﬁc categories of
AUS and suspicious follicular neoplasms, has produced little change
in this risk, decreasing the former to approximately 15% and
increasing the latter to 30%. Even under these scenarios, total thy-
roidectomy stills maintain its dominance. Today, it seems impos-
sible to reach rates of malignancy lower than 4%, although some
genetic tests could change this situation in the future [23].
Additionally, when the risk of recurrence of goiter and the need
of later reoperation were considered, total thyroidectomy was also
the ideal alternative. We used a rate of recurrence of 10%, but this
number can be higher in select populations, in which goiter is
endemic [24,25]. Only in cases of less than 7% risk of recurrence
would partial thyroidectomy be a good alternative. Additionally,
the anxiety produced by a reoperation can differ between patientsand populations, resulting in our ﬁxing this value as intermediate
between the two limits. A sensitivity analysis was performed with
these variables, showing that even in cases where the patient was
indifferent to undergoing a reoperation or not, total thyroidectomy
was still always dominant.
A probabilistic analysis that also introduced the random varia-
tions that occur in real life conﬁrmed the results of the determin-
istic analysis and showed that in almost 50% of cases, the strategy of
partial thyroidectomy results in a more costly and less effective
intervention. Only in 13% of cases were its results better than total
thyroidectomy. This helps us to generalize the present results to
other settings with similar conditions to those presented in this
study.
However, someweaknesses of this study should be realized. The
ﬁrst is that the data were taken from only one surgeon and within
the speciﬁc cost structure of a reference center. We tried to solve
this difﬁculty by performing a probabilistic sensitivity analysis, but
we understand that this approach can leave some particular situ-
ations out of the analysis. The same risk was run regarding the
utility, which was speciﬁcally ﬁxed by the authors. Second, this
analysis did not include other variables, such as the surgeons'
experience and case mix of patients. It is clear that more experi-
enced surgeons will accept these conclusions easier than those at
the beginning of their training curve; depending on the hospital,
the number of difﬁcult patients will be higher or lower. The base
case corresponded to a mean patient, and all conclusions should be
analyzed in consideration of this condition.
In conclusion, under the commonly accepted range of compli-
cations and considering the patient's preference and health system
costs, total thyroidectomy should be selected as the most cost-
effective treatment for patients with thyroid nodules with follic-
ular patterns.
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